Literature DB >> 14092073

PROLONGED PARESIS FOLLOWING GALLAMINE; A CASE REPORT.

S A FELDMAN, J A LEVI.   

Abstract

Entities:  

Keywords:  ANURIA; APNEA; GALLAMINE TRIETHIODIDE; KIDNEY, ARTIFICIAL; NEOSTIGMINE; PARALYSIS; PEPTIC ULCER PERFORATION; POSTOPERATIVE COMPLICATIONS; POTASSIUM; RESPIRATION, ARTIFICIAL; STOMACH ULCER; STREPTOMYCIN; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1963        PMID： 14092073     DOI： 10.1093/bja/35.12.804

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  7 in total

1.  Factors limiting the rate of termination of the neuromuscular blocking action of fazadinium dibromide.

Authors:  M B Tyers
Journal:  Br J Pharmacol       Date:  1978-06       Impact factor: 8.739

Review 2.  Clinical pharmacokinetics of the non-depolarising muscle relaxants.

Authors:  M I Ramzan; A A Somogyi; J S Walker; C A Shanks; E J Triggs
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

3.  Clinical pharmacokinetics and pharmacodynamics of fazadinium in renal failure.

Authors:  D R Bevan; J D D'Souza; J M Rouse; J Caldwell; R L Smith
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

4.  The effect of renal failure on the disposition and neuromuscular blocking action of pancuronium bromide.

Authors:  A A Somogyi; C A Shanks; E J Triggs
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

5.  Gallamine disposition in surgical patients with chronic renal failure.

Authors:  M I Ramzan; C A Shanks; E J Triggs
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

Review 6.  Approach to neuromuscular disorders in the intensive care unit.

Authors:  Kenneth C Gorson
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

7.  Use of the muscle relaxant atracurium in anephric patients: preliminary communication.

Authors:  J M Hunter; R S Jones; J E Utting
Journal:  J R Soc Med       Date:  1982-05       Impact factor: 18.000
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.